DNA minor groove binders as therapeutic agents

J. M. Withers, G. Padroni, S. M. Pauff, A. W. Clark, S. P. Mackay, G. A. Burley

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

This article describes the current state-of-the-art in the development of small- and medium-sized molecules that interact with double-stranded DNA (dsDNA) by minor groove binding. The supramolecular structure of dsDNA is described and how this informs the development of minor groove binding agents. The structure and biological activity of biologically derived, bioinspired, and synthetic minor groove binders (MGBs) are then evaluated. The therapeutic applications of MGBs as antiinfectives and anticancer agents are presented.

Original languageEnglish
Title of host publicationComprehensive Supramolecular Chemistry II
Subtitle of host publicationSupramolecular Medicinal Chemistry and Chemical Biology
EditorsJerry L. Atwood
Place of PublicationAmsterdam
PublisherElsevier Inc.
Chapter5.07
Pages149-178
Number of pages30
Volume5
Edition2nd
ISBN (Print)9780128031995, 9780128031988
DOIs
Publication statusPublished - 29 Jun 2017

    Fingerprint

Keywords

  • anti-infectives
  • DNA
  • gene expression
  • minor groove binding
  • polyamides
  • solid phase synthesis
  • therapeutics

Cite this

Withers, J. M., Padroni, G., Pauff, S. M., Clark, A. W., Mackay, S. P., & Burley, G. A. (2017). DNA minor groove binders as therapeutic agents. In J. L. Atwood (Ed.), Comprehensive Supramolecular Chemistry II: Supramolecular Medicinal Chemistry and Chemical Biology (2nd ed., Vol. 5, pp. 149-178). Amsterdam: Elsevier Inc.. https://doi.org/10.1016/B978-0-12-409547-2.12561-2